“Research and clinical studies are incredibly important to our organization and to the spine community,” said Michael Butler, president and CEO of Life Spine. “The PROLIFT Lateral study is one of eight active studies being executed by Life Spine currently as a part of our dedication to researching the safety and efficacy of our products. Anecdotally, we have received excellent feedback regarding the PROLIFT Lateral System, but it is integral to our core goals to validate this feedback and ensure our products are advancing the standards of spine care.”
In addition to its eight active clinical studies, Life Spine’s dedication to research extends to their in-house state-of-the-art cadaveric lab where over 350 surgeons have trained and performed product testing and validations.
One of those eight clinical studies began last August. Life Spine's foot and ankle division, Centric Medical, initiated a TARSA-LINK Stand-Alone Wedge Fixation System clinical study with Dr. Christopher Nicholas of Norfolk Foot and Ankle in Norfolk, Va.
“Wedge systems have been utilized for many years to correct flat foot deformities, however outcome studies are necessary to evaluate novel systems such as the TARSA-LINK wedge which is the first option on the market with integrated fixation,” said Dr. Nicholas, who is the principal investigator for the study.
Randy Lewis, general manager for Life Spine, noted, “Evaluating the safety and efficacy of our products is essential to Life Spine and Centric Medical. We believe we have developed a more streamlined solution in TARSA-LINK and we are excited to study the data.”
The TARSA-LINK Stand-Alone Wedge Fixation System is available in a variety of footprints and is offered in PEEK and titanium. As opposed to traditional Evans and Cottons Osteotomy procedures, TARSA-LINK is designed to reduce site irritation due to being flush in the osteotomy site, without the need for supplemental fixation.